BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 6213318)

  • 1. Facts about injectable contraceptives: memorandum from a WHO meeting.
    Bull World Health Organ; 1982; 60(2):199-210. PubMed ID: 6213318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statement on injectable contraception.
    International Planned Parenthood Federation IPPF
    IPPF Med Bull; 1982 Dec; 16(6):3-4. PubMed ID: 12338511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long acting injectable hormonal contraceptives.
    Fraser IS
    Clin Reprod Fertil; 1982 Mar; 1(1):67-88. PubMed ID: 6226351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.
    Contraception; 1983 Jul; 28(1):1-20. PubMed ID: 6226488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Swenson I; Khan AR; Jahan FA
    Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-acting Systemic Agents for the Regulation of Fertility.
    Gray RH; Parker RA; Diethelm P
    Br J Obstet Gynaecol; 1981 Mar; 88(3):317-21. PubMed ID: 7008825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
    Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
    Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
    Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable contraception: the USA perspective.
    Kaunitz AM
    IPPF Med Bull; 1992 Dec; 26(6):1-3. PubMed ID: 12346920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of the injectable contraceptive NET-EN into family planning clinics in Bangladesh.
    Rahman SS; Jabeen S; Malakar M; Rahman S; Khatoon J; Ahmed N; Chowdhury SM; Holck SE; Busca B; Akhter H
    Bull World Health Organ; 1985; 63(4):785-91. PubMed ID: 3878743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable contraceptives.
    Toppozada M
    Contracept Deliv Syst; 1982 Apr; 3(2):161-70. PubMed ID: 12338171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term contraception with Depo-Provera: a clinical evaluation.
    Mukherjea M; Mukherjee P; Biswas R
    Int J Fertil; 1980; 25(2):122-6. PubMed ID: 6117526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Injectable contraception using depot progestagens].
    Velasco Murillo V; Correu Azcona S
    Ginecol Obstet Mex; 1983 Jul; 51(315):191-7. PubMed ID: 6242048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception.
    Draper BH; Morroni C; Hoffman M; Smit J; Beksinska M; Hapgood J; Van der Merwe L
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005214. PubMed ID: 16856087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
    Fraser IS
    Contraception; 1983 Oct; 28(4):385-97. PubMed ID: 6230212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injectable contraceptives: safe and effective.
    IPPF Med Bull; 1982 Feb; 16(1):3-4. PubMed ID: 12264296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-a-month injectable contraceptives.
    Hall PE
    IPPF Med Bull; 1987 Apr; 21(2):1-2. PubMed ID: 12268597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injectable contraception.
    Elder MG
    Clin Obstet Gynaecol; 1984 Dec; 11(3):723-41. PubMed ID: 6239732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.